• 中国科学论文统计源期刊
  • 中国科技核心期刊
  • 美国化学文摘(CA)来源期刊
  • 日本科学技术振兴机构数据库(JST)

JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE ›› 2026, Vol. 28 ›› Issue (5): 874-881.DOI: 10.3969/j.issn.1671-2587.2026.05.027

Previous Articles     Next Articles

Recent Advances in Mechanisms of Erythrocyte Programmed Death and Their Pathophysiological Significance

CHEN Linfeng1, HUA Baolai2   

  1. 1Department of Blood Transfusion Medicine, Beijing Shijitan Hospital Affiliated to Capital Medical University, Beijing 100038;
    2Department of Hematology, Beijing Shijitan Hospital Affiliated to Capital Medical University, Beijing 100038
  • Received:2026-09-03 Revised:2026-09-23 Online:2026-10-20 Published:2026-11-11

Abstract: Programmed death of red blood cells is an active cellular death process that occurs in mature erythrocytes under specific physiological and pathological stimuli. Unlike apoptosis in nucleated cells, mature erythrocytes lack the classic apoptotic execution structures such as a nucleus and mitochondria, and their death modes possess unique molecular features and regulatory networks. The currently known major pathways include the eryptosis pathway characterized by phosphatidylserine externalization and cell shrinkage, the newly discovered lytic programmed death Spectosis, as well as related pathways such as ferroptosis and erythronecroptosis. These pathways form a complex interactive regulatory network through key mechanisms including calcium signaling, oxidative stress, sphingolipid metabolism, and iron metabolism. Abnormal regulation of programmed erythrocyte death is widely involved in the pathological processes of various diseases, including hemolytic anemia, sickle cell disease, sepsis, malaria, chronic kidney disease, and diabetes. Its excessive activation can lead to premature clearance of red blood cells and tissue damage, while insufficient regulation may affect erythrocyte homeostasis. This article systematically reviews the main types of programmed erythrocyte death, molecular regulatory mechanisms, and cross-talk between signaling pathways, and explores their pathophysiological significance in various diseases, which could provide a theoretical basis and new ideas for the development of diagnostic markers and therapeutic intervention strategies targeting programmed erythrocyte death.

Key words: Programmed erythrocyte death, Eryptosis, Spectosis, Hemolytic anemia, Chronic kidney disease

CLC Number: